Oral lichen planus: comparative efficacy and treatment costs-a systematic review.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
06 05 2022
Historique:
received: 04 01 2022
accepted: 11 04 2022
entrez: 7 5 2022
pubmed: 8 5 2022
medline: 11 5 2022
Statut: epublish

Résumé

To compare the reported efficacy and costs of available interventions used for the management of oral lichen planus (OLP). A systematic literature search was performed from database inception until March 2021 in MEDLINE via PubMed and the Cochrane library following PRISMA guidelines. Only randomized controlled trials (RCT) comparing an active intervention with placebo or different active interventions for OLP management were considered. Seventy (70) RCTs were included. The majority of evidence suggested efficacy of topical steroids (dexamethasone, clobetasol, fluocinonide, triamcinolone), topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporine), topical retinoids, intra-lesional triamcinolone, aloe-vera gel, photodynamic therapy, and low-level laser therapies for OLP management. Based on the estimated cost per month and evidence for efficacy and side-effects, topical steroids (fluocinonide > dexamethasone > clobetasol > triamcinolone) appear to be more cost-effective than topical calcineurin inhibitors (tacrolimus > pimecrolimus > cyclosporine) followed by intra-lesional triamcinolone. Of common treatment regimens for OLP, topical steroids appear to be the most economical and efficacious option followed by topical calcineurin inhibitors. Large-scale multi-modality, prospective trials in which head-to-head comparisons interventions are compared are required to definitely assess the cost-effectiveness of OLP treatments.

Identifiants

pubmed: 35524296
doi: 10.1186/s12903-022-02168-4
pii: 10.1186/s12903-022-02168-4
pmc: PMC9074269
doi:

Substances chimiques

Calcineurin Inhibitors 0
Cyclosporins 0
Steroids 0
Triamcinolone 1ZK20VI6TY
Fluocinonide 2W4A77YPAN
Dexamethasone 7S5I7G3JQL
Clobetasol ADN79D536H
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

161

Informations de copyright

© 2022. The Author(s).

Références

Oral Dis. 2017 Jan;23(1):62-68
pubmed: 27543905
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):161-7
pubmed: 7552878
J Oral Pathol Med. 2007 Mar;36(3):142-6
pubmed: 17305635
Quintessence Int. 2012 Oct;43(9):793-800
pubmed: 23041995
Oral Dis. 2018 Jul;24(5):772-777
pubmed: 29297958
J Investig Clin Dent. 2017 Aug;8(3):
pubmed: 27344987
Bull Group Int Rech Sci Stomatol Odontol. 1995 Jan-Feb;38(1-2):33-8
pubmed: 7881264
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Feb;105(2):187-93
pubmed: 18230389
Iran J Otorhinolaryngol. 2015 Mar;27(79):119-26
pubmed: 25938083
Lasers Med Sci. 2015 Jul;30(5):1475-80
pubmed: 25487185
Am J Health Syst Pharm. 2005 Mar 1;62(5):485-91
pubmed: 15745911
Am J Med Sci. 2011 Dec;342(6):447-51
pubmed: 21681079
Cochrane Database Syst Rev. 2020 Feb 28;2:CD001168
pubmed: 32108333
Photodiagnosis Photodyn Ther. 2017 Dec;20:159-164
pubmed: 28669793
Acta Derm Venereol. 2006;86(3):227-9
pubmed: 16710580
J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1061-7
pubmed: 21175873
Ann Dermatol. 2015 Oct;27(5):485-91
pubmed: 26512161
Homeopathy. 2009 Jan;98(1):40-4
pubmed: 19135958
Clin Oral Investig. 2007 Sep;11(3):283-8
pubmed: 17483968
Arch Dermatol. 2007 Apr;143(4):472-6
pubmed: 17438179
Br J Dermatol. 1982 Jan;106(1):77-80
pubmed: 7037037
Photodiagnosis Photodyn Ther. 2018 Mar;21:404-408
pubmed: 29414735
J Pharm Bioallied Sci. 2016 Oct;8(Suppl 1):S86-S89
pubmed: 27829754
Int J Dermatol. 2003 Apr;42(4):308-11
pubmed: 12694502
Aust Dent J. 2021 Sep;66(3):295-303
pubmed: 33682925
J Oral Pathol Med. 2002 Jan;31(1):23-7
pubmed: 11896819
J Oral Pathol Med. 2010 Nov;39(10):735-40
pubmed: 20923446
Clin Oral Investig. 2019 Feb;23(2):947-956
pubmed: 29909565
Oral Dis. 2017 Jul;23(5):660-668
pubmed: 28168769
Probiotics Antimicrob Proteins. 2020 Dec;12(4):1340-1348
pubmed: 32506228
Oral Dis. 2011 Jan;17(1):95-101
pubmed: 20659263
Br J Dermatol. 1977 Jun;96(6):659-62
pubmed: 326295
J Clin Diagn Res. 2017 Apr;11(4):ZC89-ZC93
pubmed: 28571271
J Biomed Opt. 2014 Jun;19(6):068002
pubmed: 24887747
J Am Acad Dermatol. 2008 Apr;58(4):596-602
pubmed: 18158199
Photomed Laser Surg. 2011 Jun;29(6):421-5
pubmed: 21214369
Oral Dis. 1999 Jan;5(1):44-9
pubmed: 10218041
J Clin Periodontol. 2008 Mar;35(3):244-9
pubmed: 18269664
J Oral Pathol Med. 2009 Aug;38(7):551-8
pubmed: 19486267
Arch Dermatol. 1986 May;122(5):534-6
pubmed: 3518638
BMJ Open. 2018 Oct 8;8(10):e024083
pubmed: 30297352
Br J Dermatol. 2008 Sep;159(4):936-41
pubmed: 18647310
Int J Dermatol. 2016 Jan;55(1):101-5
pubmed: 26147635
J Investig Clin Dent. 2017 Nov;8(4):
pubmed: 27633647
Int J Dermatol. 2012 Nov;51(11):1371-8
pubmed: 23067089
Int J Oral Maxillofac Surg. 2012 Oct;41(10):1265-9
pubmed: 22784653
J Eur Acad Dermatol Venereol. 2014 Apr;28(4):475-82
pubmed: 23451852
J Oral Pathol Med. 2009 Feb;38(2):227-33
pubmed: 19141065
J Am Acad Dermatol. 2007 Nov;57(5):806-13
pubmed: 17658663
Dermatol Res Pract. 2020 May 20;2020:4298193
pubmed: 32518558
J Laryngol Otol. 2017 Jan;131(1):69-76
pubmed: 27917729
Br J Dermatol. 1995 May;132(5):790-4
pubmed: 7772487
N Engl J Med. 1990 Aug 2;323(5):290-4
pubmed: 2195345
J Dent (Tehran). 2015 Nov;12(11):789-96
pubmed: 27507989
Indian J Dent Res. 2014 Nov-Dec;25(6):711-6
pubmed: 25728101
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):47-55
pubmed: 16831672
Oral Surg Oral Med Oral Pathol. 1993 Feb;75(2):181-5
pubmed: 8426717
Br J Dermatol. 2008 Mar;158(3):573-7
pubmed: 18093246
J Oral Pathol Med. 2001 Nov;30(10):611-7
pubmed: 11722711
J Periodontol. 2005 Apr;76(4):627-35
pubmed: 15857105
Oral Dis. 2019 Nov;25(8):1954-1963
pubmed: 31478283
Oral Dis. 2002 Nov;8(6):291-5
pubmed: 12477060
J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):714-718
pubmed: 33088702
J Oral Pathol Med. 1992 Nov;21(10):456-8
pubmed: 1460584
J Clin Exp Dent. 2016 Dec 1;8(5):e566-e570
pubmed: 27957272
Indian J Dent. 2015 Jan-Mar;6(1):14-9
pubmed: 25767355
JAMA Dermatol. 2020 Feb 1;156(2):172-181
pubmed: 31895418
Indian J Dent Res. 2011 Sep-Oct;22(5):639-43
pubmed: 22406705

Auteurs

Shaiba Sandhu (S)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA. ssandhu@mgh.harvard.edu.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA. ssandhu@mgh.harvard.edu.
Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. ssandhu@mgh.harvard.edu.

Brittany A Klein (BA)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Malak Al-Hadlaq (M)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Prazwala Chirravur (P)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Amal Bajonaid (A)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Yuanming Xu (Y)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Rossella Intini (R)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Mai Hussein (M)

Harvard Medical School, Boston, MA, USA.
Ministry of Health and Population, Cairo, Egypt.

Piamkamon Vacharotayangul (P)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Herve Sroussi (H)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Nathaniel Treister (N)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Stephen Sonis (S)

Division of Oral Medicine and Dentistry, Brigham and Women's Hospital/ Dana Farber Cancer Institute, Boston, USA.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH